Resmed Stocks 2024

Resmed Stocks

147.46 M

Resmed Dividend yield

0.84 %

Ticker

RMD

ISIN

US7611521078

WKN

895878

In 2024, Resmed had 147.46 M outstanding stocks, a 0% change from the 147.46 M stocks in the previous year.

The Resmed Stocks history

YEARNUMBER OF STOCKS (undefined USD)
2029e147.46
2028e147.46
2027e147.46
2026e147.46
2025e147.46
2024e147.46
2023147.46
2022147.04
2021146.45
2020145.7
2019144.5
2018144
2017142.5
2016141.7
2015142.7
2014144.4
2013146.4
2012149.3
2011157.2
2010155.1
2009154.2
2008157.4
2007156.5
2006154.3
2005149.9
2004140.5

Resmed Aktienanalyse

What does Resmed do?

ResMed Inc. is a global leading provider of medical devices for the treatment of sleep disorders and respiratory diseases. The company was founded in Australia by Peter Farrell, a former employee of the University of New South Wales, in 1989. Today, ResMed is headquartered in San Diego, California, and employs over 7,500 people worldwide. Business model: ResMed's business model is based on providing medical products and solutions for the treatment of sleep apnea and other respiratory diseases. The company develops and distributes masks, devices, and accessories that help patients breathe better and achieve restful sleep. ResMed also offers cloud-based software solutions and services to assist doctors and sleep labs in diagnosing and monitoring patients. Products and divisions: ResMed's product range can be divided into four main divisions: Sleep & Respiratory Care, Software as a Service (SaaS), Technologies, and Dental Solutions. Sleep & Respiratory Care: In this division, ResMed offers a wide range of masks, devices, and accessories for the treatment of sleep apnea and other respiratory diseases. The most well-known products include the AirSense and AirMini devices, equipped with Automatic Sleep Detection and AutoSet algorithm to optimize respiratory pressure. ResMed also offers a range of CPAP masks, nasal and full face masks, as well as nasal pillow masks. Software as a Service (SaaS): ResMed's cloud-based software solutions and services are offered under the brand AirView. They include diagnostic tools, patient monitoring systems, and analysis tools. AirView allows doctors to access their patients' medical data captured by ResMed devices and monitor this data in real-time. Technologies: ResMed's Technologies division focuses on the development of advanced sensors for respiratory and sleep monitoring. Products include the S+, a smart sleep tracking system that operates without direct body contact, and the Reveal-LTE, an implant for monitoring heart and respiratory rates in patients with heart failure. Dental Solutions: ResMed has also developed products for dentistry to assist patients with mild to moderate upper airway obstruction. Products include the Narval CC, a custom-made dental device for the treatment of snoring and sleep apnea, and the Tap Pap nasal pillow oral appliance, a non-invasive mouthguard. Conclusion: ResMed is a leading provider of medical devices and solutions for the treatment of sleep apnea and other respiratory diseases. The company offers innovative products and technologies that help patients breathe better and achieve restful sleep. ResMed's cloud-based software solutions enable doctors to monitor their patients' health in real-time and develop effective diagnosis and treatment strategies. With its wide range of products, innovation, and highly qualified team of scientists, engineers, and medical professionals, ResMed will continue to play an important role in the healthcare industry. Resmed ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Stocks Details

Evaluating Resmed's Shares Outstanding

Resmed's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.

Year-to-Year Comparison

Tracking the changes in Resmed’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.

Impact on Investments

For investors, understanding Resmed’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.

Interpreting Changes in Shares Outstanding

Variances in Resmed’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.

Frequently Asked Questions about Resmed Stock

How many stocks are there of Resmed?

The current number of stocks of Resmed is 147.46 M undefined.

What does Number of Shares / OutstandingShares mean?

The outstanding shares (or issued shares) of Resmed are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.

How has the number of shares of Resmed evolved in recent years?

The number of shares of Resmed has increased by 0% gestiegen compared to last year.

What does the number of shares mean for investors?

The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.

Why does the number of stocks fluctuate?

There are various factors that can lead to a change. Resmed as a company can issue new shares, carry out stock splits or reverse splits.

Does the number of shares have an impact on the performance of Resmed?

There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

How much dividend does Resmed pay?

Over the past 12 months, Resmed paid a dividend of 1.84 USD . This corresponds to a dividend yield of about 0.84 %. For the coming 12 months, Resmed is expected to pay a dividend of 2.11 USD.

What is the dividend yield of Resmed?

The current dividend yield of Resmed is 0.84 %.

When does Resmed pay dividends?

Resmed pays a quarterly dividend. This is distributed in the months of September, December, March, June.

How secure is the dividend of Resmed?

Resmed paid dividends every year for the past 0 years.

What is the dividend of Resmed?

For the upcoming 12 months, dividends amounting to 2.11 USD are expected. This corresponds to a dividend yield of 0.96 %.

In which sector is Resmed located?

Resmed is assigned to the 'Health' sector.

Wann musste ich die Aktien von Resmed kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Resmed from 6/13/2024 amounting to 0.48 USD, you needed to have the stock in your portfolio before the ex-date on 5/8/2024.

When did Resmed pay the last dividend?

The last dividend was paid out on 6/13/2024.

What was the dividend of Resmed in the year 2023?

In the year 2023, Resmed distributed 1.72 USD as dividends.

In which currency does Resmed pay out the dividend?

The dividends of Resmed are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Resmed stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Resmed

Our stock analysis for Resmed Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Resmed Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.